- Emmert Roberts: National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. ORCID
There has been substantial recent renewed interest and investment to assess the therapeutic potential of psychedelic compounds in addiction disorders. This editorial discusses the available evidence from randomised trials and future research directions in the field, together with potential implications for patients, professionals and the wider addiction treatment system.